FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Device UDI Information Collection Revision

Federal Register notice: FDA sends to OMB an information collection revision entitled Medical Device Labeling Requirements; Unique Device Identificati...

latest-news-card-1
Federal Register

Guide on Neonatal Neurodevelopmental Safety

Federal Register notice: FDA makes available a draft guidance entitled Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neon...

latest-news-card-1
Human Drugs

Soligenix Gets Refuse-to File Letter on HyBryte

FDA issues Soligenix a refuse-to-file letter for its HyBryte (synthetic hypericin) NDA that is seeking an indication for treating early stage cutaneou...

latest-news-card-1
Human Drugs

CGMP Violations in Delta Kozmetik Sanayi Inspection

FDA warns Tuzia/Istanbul, Turkey-based Delta Kozmetik about CGMP violations in its production of finished drugs.

latest-news-card-1
Medical Devices

Multiple Violations in Unapproved Wintech Medipro Masks

FDA warns Katy, TX-based Wintech Medipro about multiple violations in its manufacturing and distribution of unapproved surgical masks.

latest-news-card-1
Human Drugs

11 Republicans See FDA/Industry Revolving Door

Eleven Republican members of Congress ask FDA and other agencies to respond to disputed claims that FDA drug reviewers take it easy on companies for w...

latest-news-card-1
Human Drugs

FDA Staff Take Aim on ICH Model-Informed Development

FDA says staff from CDER and CBER are participating on a new International Council on Harmonization formal expert working group to develop a guideline...

latest-news-card-1
Human Drugs

FDA Alternative Review Tools Critical in Decisions: Study

FDA researchers say the alternative tools employed in CDER inspections during the pandemic were critical to informing agency regulatory decisions whil...

Human Drugs

CDER OPQ to Continue Some Remote Assessments

The CDER Office of Pharmaceutical Quality 2022 annual reports touts how alternative review techniques aided regulatory decision-making during the Covi...

latest-news-card-1
Biologics

Marks Wants Project Orbis for Cell/Gene Therapies

CBER director Peter Marks tells a conference he would like to see a Project Orbis-style multi-national effort to spur the development of cell and gene...